Primordia Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.43 M
- Company Age 7 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -33.80%
- Profit Growth -258.07%
- Ebitda -283.33%
- Net Worth -24.38%
- Total Assets 103.62%
About Primordia Lifesciences
Primordia Lifesciences Private Limited (PLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 January 2018 (Seven years 9 days old ). Its registered office is in Idukki, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.43 M, as per Ministry of Corporate Affairs (MCA) records.
Joe Joseph, Anu Joseph, and Naveen Antony serve as directors at the Company.
Company Details
-
Location
Idukki, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73200KL2018PTC051880
-
Company No.
051880
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jan 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Primordia Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anu Joseph
|
Managing Director | 22-Jan-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Joe Joseph
|
Director | 29-Sep-2021 | Current |
| Naveen Antony | Director | 12-Oct-2022 | Current |
Financial Performance of Primordia Lifesciences.
Primordia Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.8% decrease. The company also saw a substantial fall in profitability, with a 258.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Primordia Lifesciences?
In 2023, Primordia Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jyat Honeycomb Properties Private LimitedJoe Joseph and Anu Joseph are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Primordia Lifesciences?
Unlock and access historical data on people associated with Primordia Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Primordia Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primordia Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
